Triglyceride disorder - Symptoms, Causes, Treatment & Prevention

Overview

Triglyceride disorder, often referred to as hypertriglyceridemia, is a condition in which the blood level of triglycerides (a type of fat) is higher than normal. Triglycerides are the main form of stored energy in the body and are carried in the bloodstream within lipoproteins. When concentrations rise markedly, they can contribute to atherosclerosis, pancreatitis, and other metabolic complications.

Who it affects: The disorder can appear at any age but is most common in adults aged 30‑70 years. It occurs more frequently in men than women, though post‑menopausal women see a rise in prevalence. Certain ethnic groups—particularly people of South Asian, Hispanic, and Indigenous North American ancestry—have higher rates.

Prevalence: According to the National Health and Nutrition Examination Survey (NHANES), about 30 % of U.S. adults have serum triglycerides ≥150 mg/dL (1.7 mmol/L), the threshold for hypertriglyceridemia. Severe hypertriglyceridemia (≥500 mg/dL) affects roughly 1‑2 % of the population, while extremely high levels (≥1,000 mg/dL) are rare (<0.1 %) but carry a high risk of pancreatitis.

Symptoms

Most people with mildly elevated triglycerides are asymptomatic. When levels become markedly high, clinical signs may emerge:

• Abdominal pain: Sudden, severe, often radiating to the back—suggestive of acute pancreatitis.
• Fatty streaks on the skin (xanthomas): Yellowish, flat or slightly raised lesions, commonly on the elbows, knees, or buttocks.
• Eruptive xanthomas: Small, red‑to‑yellow papules that may appear on the trunk or limbs when triglycerides exceed 1,000 mg/dL.
• Hepatosplenomegaly: Enlarged liver or spleen detectable on physical exam or imaging, usually in genetic forms.
• Fatigue or generalized weakness: Indirectly related to associated metabolic disturbances.
• Changes in vision: Rarely, very high triglycerides can cause a milky appearance of the blood (lipemia retinalis) observable by an eye doctor.

Because many individuals have no warning signs, routine lipid screening is essential.

Causes and Risk Factors

Primary (Genetic) Causes

• Familial hypertriglyceridemia (FHTG): An autosomal dominant disorder affecting ~1 % of the population.
• Familial chylomicronemia syndrome (FCS): Rare (<1 per million) recessive condition caused by defects in lipoprotein lipase (LPL) or its cofactors.
• Other monogenic disorders: Mutations in APOA5, GPIHBP1, or LMF1 can elevate triglycerides.

Secondary (Acquired) Causes

• Obesity and metabolic syndrome
• Type 2 diabetes mellitus (especially when poorly controlled)
• Excessive alcohol consumption
• High‑carbohydrate or high‑sugar diets (especially fructose)
• Medications: glucocorticoids, estrogen therapy, retinoids, beta‑blockers, protease inhibitors, some antipsychotics
• Kidney disease (nephrotic syndrome) and liver disease (non‑alcoholic fatty liver disease)
• Pregnancy (physiologic hypertriglyceridemia)

Risk Factors

• Age >40 years
• Male sex
• Family history of dyslipidemia or premature cardiovascular disease
• Sedentary lifestyle
• Smoking
• High intake of saturated fats, trans fats, and simple sugars

Diagnosis

Diagnosing a triglyceride disorder involves a combination of history, physical exam, and laboratory testing.

1. Fasting Lipid Panel

• Normal: <150 mg/dL (1.7 mmol/L)
• Borderline high: 150‑199 mg/dL
• High: 200‑499 mg/dL
• Very high: ≥500 mg/dL – risk of pancreatitis rises sharply.

Guidelines from the American College of Cardiology (ACC) and the American Heart Association (AHA) recommend fasting for 8‑12 hours before blood draw.

2. Repeat Testing

Because triglycerides can fluctuate after meals, a second fasting measurement is usually performed to confirm persistent elevation.

3. Secondary Evaluation

• Blood glucose & HbA1c (to screen for diabetes)
• Liver function tests, renal panel
• Thyroid‑stimulating hormone (TSH) – hypothyroidism can raise triglycerides
• Alcohol use questionnaire

4. Genetic Testing

Indicated when triglycerides are >1,000 mg/dL, when there is a strong family history, or when standard therapy fails. Panels may include LPL, APOA5, GPIHBP1, and related genes.

5. Imaging

Ultrasound or CT may be ordered if pancreatitis is suspected or to assess hepatic steatosis.

Treatment Options

Treatment aims to lower triglyceride levels, reduce cardiovascular risk, and prevent pancreatitis.

1. Lifestyle Modifications (First‑line)

• Dietary changes: Reduce total calories, limit simple sugars (especially fructose), avoid trans fats, and replace saturated fats with monounsaturated/polyunsaturated fats. The Mediterranean diet is evidence‑based for triglyceride reduction.
• Alcohol restriction: Eliminate or limit to ≤1 drink/day for women and ≤2 drinks/day for men; abstain if triglycerides >500 mg/dL.
• Weight loss: 5‑10 % body‑weight reduction can lower triglycerides by 10‑20 % (Mayo Clinic). Aim for ≥150 min/week of moderate‑intensity aerobic activity.
• Physical activity: Regular exercise improves lipoprotein lipase activity, enhancing triglyceride clearance.

2. Pharmacologic Therapy

Guidelines recommend fibrates or high‑dose omega‑3s for triglycerides ≥500 mg/dL, especially when pancreatitis risk is high (ACC/AHA 2019). Statins should be used universally when LDL‑C is elevated or cardiovascular disease is present.

3. Procedural/Advanced Therapies

• Apheresis: Lipoprotein apheresis can acutely lower triglycerides in refractory cases or during an acute pancreatitis episode.
• Liver transplantation: Rarely considered for severe genetic forms with liver failure.

Living with Triglyceride Disorder

Daily Management Tips

• Start meals with a protein or healthy‑fat source to blunt post‑prandial triglyceride spikes.
• Read nutrition labels; aim for <10 g of added sugars per day.
• Keep a food diary for the first month to identify hidden sugar sources (e.g., sweetened yogurts, sauces).
• Stay hydrated – adequate water supports lipid metabolism.
• Schedule regular lipid checks: every 3‑6 months until stable, then annually.
• If taking fibrates or statins, have baseline and periodic liver function tests and creatine kinase measured.
• Use a wearable activity tracker to meet weekly exercise goals.
• Join a support group or online forum for people with dyslipidemia for motivation and recipe ideas.

Prevention

Because many secondary causes are modifiable, prevention focuses on lifestyle and early detection.

• Screen fasting triglycerides at least once every 5 years for adults >20 years, or earlier if risk factors exist (USPSTF).
• Adopt a Mediterranean‑style diet rich in fish, nuts, olive oil, legumes, and plenty of vegetables.
• Limit sugary beverages – replace with water, unsweetened tea, or coffee.
• Maintain a healthy BMI (18.5‑24.9 kg/m²).
• Quit smoking; use nicotine‑replacement or prescription aids if needed.
• Control blood pressure, glucose, and LDL‑C through both medication and lifestyle, as these interact with triglyceride metabolism.

Complications

If left untreated, elevated triglycerides can lead to serious health issues:

• Acute pancreatitis: Risk rises dramatically when triglycerides exceed 500 mg/dL, with mortality up to 10 % in severe cases (NIH).
• Atherosclerotic cardiovascular disease (ASCVD): While LDL‑C is the primary driver, high triglycerides independently increase risk of coronary artery disease, stroke, and peripheral arterial disease.
• Non‑alcoholic fatty liver disease (NAFLD): Hypertriglyceridemia promotes hepatic steatosis, which can progress to steatohepatitis and cirrhosis.
• Metabolic syndrome: A constellation of hypertension, abdominal obesity, hyperglycemia, and dyslipidemia that triples cardiovascular risk.
• Pancreatic lipomatosis and chronic pancreatitis: Recurrent inflammation may impair exocrine function.

When to Seek Emergency Care

References:

1. Mayo Clinic. “Triglycerides: Why they matter.” Accessed June 2026.
2. American Heart Association/ACC. 2019 Guideline on the Primary Prevention of Cardiovascular Disease. Circulation 2019.
3. National Institutes of Health. “Hypertriglyceridemia.” NIH Health Topics. 2024.
4. Centers for Disease Control and Prevention. “Fast Facts: Triglycerides.” 2023.
5. World Health Organization. “Noncommunicable diseases country profiles 2023.” WHO. 2023.
6. Cleveland Clinic. “High triglycerides (hypertriglyceridemia).” 2025.